RxSight SG&A Expense (TTM) Insights

RxSight Inc (RXST)

57.10 +0.15 (+0.26%) USD | NASDAQ | Jul 08, 16:00

57.10 0.00 (0.00%) After-Hours: 19:04

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	81.87M
December 31, 2023	74.80M
September 30, 2023	69.37M
June 30, 2023	65.15M
March 31, 2023	61.30M
December 31, 2022	58.66M
September 30, 2022	54.55M

Date	Value
June 30, 2022	48.70M
March 31, 2022	40.81M
December 31, 2021	32.80M
September 30, 2021	25.59M
June 30, 2021	20.34M
March 31, 2021	17.09M
December 31, 2020	15.18M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

15.18M

Minimum

Dec 2020

81.87M

Maximum

Mar 2024

47.59M

Average

51.62M

Median

SG&A Expense (TTM) Benchmarks